drugset / Trial / NCT02191813
Study to Determine the Ability of Seresis to Act as a Skin Protection Agent in Healthy Young Female Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to detect the efficacy of Seresis® in reducing the damage produced on the skin by Matrix-metalloproteinases (MMP) and by oxidative stress (marker: heme oxygenase-1 expression) activated by UV radiation
Timeline
- Start
- 2000-03
- Primary completion
- 2000-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seresis® | Unknown | — | — |
Indications
No indication recorded.